Works matching IS 21638306 AND DT 2025 AND VI 14 AND IP 5

Results: 17

Historical Use of Markov Model and Posterior Predictive Checks in Pharmacometrics.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 817, doi. 10.1002/psp4.70031

By:

Girard, Pascal;
Kastrissios, Helen

Publication type:

Article

Harnessing Open‐Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 822, doi. 10.1002/psp4.70028

By:

Dallmann, André;
Feick, Denise;
Balazki, Pavel;
Benamara, Salih;
Burghaus, Rolf;
Chenel, Marylore;
Choi, Siak‐Leng;
Cordes, Henrik;
Guimarães, Mariana;
Hamadeh, Abdullah;
Ince, Ibrahim;
Job, Kathleen M.;
Kanacher, Tobias;
Kovar, Andreas;
Kuepfer, Lars;
Lippert, Jörg;
Macente, Julia;
Nauwelaerts, Nina;
Niederalt, Christoph;
Peters, Sheila

Publication type:

Article

SpatialCNS‐PBPK: An R/Shiny Web‐Based Application for Physiologically Based Pharmacokinetic Modeling of Spatial Pharmacokinetics in the Human Central Nervous System and Brain Tumors.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 864, doi. 10.1002/psp4.70026

By:

Wickramasinghe, Charuka D.;
Kim, Seongho;
Li, Jing

Publication type:

Article

Less Is More: Design Considerations for Interactive Pharmacometrics Tools—A Case Study Using the Model Visualization Platform (MVP) App.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 819, doi. 10.1002/psp4.70023

By:

Choy, Steve;
Kim, Jin Gyu;
Korell, Julia

Publication type:

Article

Using the Simcyp R Package for PBPK Simulation Workflows With the Simcyp Simulator.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 853, doi. 10.1002/psp4.70022

By:

Onasanwo, Anthonia M.;
Mittapelly, Naresh;
Shireman, Laura;
Vinden, Barry;
McNally, Kevin;
Craig, James;
Bois, Frederic Y.

Publication type:

Article

Synthetic Data in Healthcare and Drug Development: Definitions, Regulatory Frameworks, Issues.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 840, doi. 10.1002/psp4.70021

By:

Pasculli, Giuseppe;
Virgolin, Marco;
Myles, Puja;
Vidovszky, Anna;
Fisher, Charles;
Biasin, Elisabetta;
Mourby, Miranda;
Pappalardo, Francesco;
D'Amico, Saverio;
Torchia, Mario;
Chebykin, Alexander;
Carbone, Vincenzo;
Emili, Luca;
Roeshammar, Daniel

Publication type:

Article

Using Pharmacokinetic and Pharmacodynamic Analysis to Optimize the Dosing Regimens of Fanastomig (EMB‐02) in Patients With Advanced Solid Tumors.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 975, doi. 10.1002/psp4.70011

By:

Jiang, Chengjun;
Ren, Fang;
Zhang, Mingfei;
Lu, Qiaoyang;
Zeng, Shuqi;
Yang, Guang;
Zhu, Yonghong

Publication type:

Article

Evaluation of Adefovir PBPK Model to Assess Biomarker‐Informed OAT1 Drug–Drug Interaction and Effect of Chronic Kidney Disease.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 964, doi. 10.1002/psp4.70010

By:

Tan, Shawn Pei Feng;
Wu, Huaying;
Rostami‐Hodjegan, Amin;
Scotcher, Daniel;
Galetin, Aleksandra

Publication type:

Article

Population Pharmacokinetic/Pharmacodynamic and Exposure–Response Modeling of Garadacimab in Healthy Volunteers and Patients With Hereditary Angioedema.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 954, doi. 10.1002/psp4.70009

By:

Garcia, Ramon;
Cheng, Shen;
Glassman, Fiona;
Sharma, Ankur;
De Miguel‐Lillo, Bernardo;
Wiens, Matthew;
Johnston, Curtis;
Lawo, John‐Philip;
Pragst, Ingo;
French, Jonathan;
Polhamus, Dan;
Nandy, Partha

Publication type:

Article

A Population Pharmacokinetic Model to Inform Extension of the Eteplirsen Dosing Regimen Across the Broad DMD Population.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 891, doi. 10.1002/psp4.70001

By:

Patel, Yogesh;
Orogun, Larry;
Yocum, Nicole;
Rodino‐Klapac, Louise R.;
East, Lilly

Publication type:

Article

Toward Precision Dosing of Lamotrigine During Pregnancy: Physiologically Based Pharmacokinetic Modeling and Simulation.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 929, doi. 10.1002/psp4.70007

By:

Qian, Yudie;
Wu, Wanhong;
Ke, Chengjie;
Liu, Siting;
Chen, Jiarui;
Chen, Yuying;
Guo, Xianzhong;
Lin, Weiwei

Publication type:

Article

Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET‐Guided Verification.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 918, doi. 10.1002/psp4.70006

By:

van der Gaag, Suzanne;
Jordens, Tamara;
Yaqub, Maqsood;
Grijseels, Robbin;
van Valkengoed, Daan W.;
de Langen, Evelien N.;
van den Broek, Ruben;
Thijssen, Victor L. J. L.;
de Langen, Adrianus J.;
Kouwenhoven, Mathilde C. M.;
Bahce, Idris;
Westerman, Bart A.;
Hendrikse, N. Harry;
Bartelink, Imke H.

Publication type:

Article

Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 904, doi. 10.1002/psp4.70005

By:

Thakur, Aarzoo;
Mathialagan, Sumathy;
Kimoto, Emi;
Varma, Manthena V. S.

Publication type:

Article

PBPK Modeling: Empowering Drug Development and Precision Dosing in China.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 828, doi. 10.1002/psp4.70004

By:

Yang, Dongsheng;
Li, Jian;
Mak, Wen Yao;
Zheng, Aole;
Zhu, Xiao;
He, Qingfeng;
Wang, Yuzhu;
Xiang, Xiaoqiang

Publication type:

Article

Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 941, doi. 10.1002/psp4.70008

By:

Ujihira, Yuki;
Tan, Shawn Pei Feng;
Scotcher, Daniel;
Galetin, Aleksandra

Publication type:

Article

Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 881, doi. 10.1002/psp4.70000

By:

Arrington, Leticia;
van Dijkman, Sven C.;
Plan, Elodie L.;
Karlsson, Mats O.

Publication type:

Article

Issue Information.

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 813, doi. 10.1002/psp4.13172
Publication type:: Article